Home/Filings/4/0001209191-22-007311
4//SEC Filing

Rona Jeffrey A 4

Accession 0001209191-22-007311

CIK 0001636651other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 6:22 PM ET

Size

5.4 KB

Accession

0001209191-22-007311

Insider Transaction Report

Form 4
Period: 2022-02-03
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-03+218,750218,750 total
    Exercise: $2.72Exp: 2032-02-02Common Stock (218,750 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 3, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001311404

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:22 PM ET
Size
5.4 KB